Samsara BioCapital as of Dec. 31, 2019
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 19 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 24.0 | $50M | 404k | 123.92 | |
| Springworks Therapeutics (SWTX) | 12.1 | $25M | 654k | 38.49 | |
| Allakos | 11.1 | $23M | 243k | 95.36 | |
| Odonate Therapeutics Ord | 8.1 | $17M | 523k | 32.45 | |
| Principia Biopharma | 8.1 | $17M | 307k | 54.78 | |
| Sutro Biopharma (STRO) | 5.9 | $12M | 1.1M | 11.00 | |
| Syros Pharmaceuticals | 5.4 | $11M | 1.7M | 6.52 | |
| Atreca Inc Cl A (BCEL) | 4.4 | $9.1M | 591k | 15.47 | |
| Aravive | 3.8 | $7.9M | 576k | 13.67 | |
| Hookipa Pharma Inc equity | 3.1 | $6.5M | 530k | 12.23 | |
| Iveric Bio | 2.9 | $6.0M | 700k | 8.58 | |
| Millendo Therapeutics | 2.3 | $4.8M | 715k | 6.74 | |
| Liquidia Technologies (LQDA) | 2.0 | $4.1M | 959k | 4.27 | |
| Bellus Health | 1.8 | $3.7M | 489k | 7.55 | |
| Pieris Pharmaceuticals | 1.2 | $2.5M | 704k | 3.62 | |
| Urovant Sciences | 1.2 | $2.4M | 158k | 15.51 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $2.1M | 119k | 17.81 | |
| Sunesis Pharmaceuticals Inc Ne | 1.0 | $2.0M | 5.9M | 0.34 | |
| Catabasis Pharmaceuticals Ord | 0.8 | $1.8M | 300k | 5.91 |
